AI assistant
TEKCAPITAL PLC — AGM Information 2018
May 30, 2018
7955_dva_2018-05-30_873ab095-2348-4f0f-a4c8-02da6c1246bb.html
AGM Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7089P
Tekcapital plc
30 May 2018
30 May 2018
Tekcapital plc
("Tekcapital" or the "Company")
Result of Annual General Meeting
Tekcapital plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from university technology, announces that all resolutions were duly passed at its Annual General Meeting held earlier today.
For further information, please contact:
| Tekcapital Plc | Via Walbrook PR |
| Clifford M. Gross, Ph.D. | |
| Allenby Capital Limited (Nominated Adviser & Joint Broker) | +44 (0) 20 3328 5656 |
| Jeremy Porter / Alex Brearley | |
| Dowgate Capital Stockbrokers (Joint Broker) | +44 (0) 1293 517744 |
| David Poutney / James Serjeant | |
| Walbrook PR Ltd | +44 (0) 20 7933 8780 |
| Paul Cornelius / Helen Cresswell / Sam Allen | [email protected] |
Tekcapital plc - The World's Largest University Network for Open Innovation
Tekcapital's objective is to create value from investing in new, university-developed intellectual properties. Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find, evaluate, acquire and license university-developed technology. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com
LEI: 213800GOJTOV19FIFZ85
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
RAGBBGDUBUXBGIG